。ShengdaPharm Corporate Restructuring Notice(2018.10.1)
。2018 CPhI & P-MEC India ShengdaPharm(2018.12.12-14)
。China Jiangxi New GMP factory launches celebration(2017.11.18)
- You are here :
- ShengdaPharm
- /News
Products Categories
- Products (764)
- Active small molecule (121)
- API & Intermediates (146)
- Afatinib (6)
- Alectinib (6)
- Betahistine (2)
- Bictegravir (7)
- Cabozantinib S-Malate (4)
- Ceritinib (9)
- Crizotinib (4)
- Dapagliflozin (5)
- Entrectinib (1)
- Flumazenil (1)
- Glecaprevir (5)
- Grazoprevir (6)
- Ibrutinib (10)
- Lapatinib (1)
- Lapatinib Ditosylate (1)
- Luliconazole (3)
- Napabucasin (1)
- Niraparib (6)
- Olaparib (4)
- Pibrentasvir (5)
- Plant Extracts (4)
- Polypeptide (3)
- Ponatinib (2)
- Posaconazole (5)
- Poziotinib (1)
- Regorafenib (3)
- Silodosin (4)
- Sofosbuvir (4)
- Sorafenib (5)
- Ticagrelor (4)
- Tofacitinib (9)
- Voxilaprevir (8)
- Unclassified Products (492)
New Products
Tags Cloud
91-17-8
162012-67-1
231277-92-2
461432-23-5
848133-35-7
913611-97-9
1009119-65-6
1022150-12-4
1028252-16-5
1092364-38-9
1256580-46-7
1360828-80-3
AP26113 intermediate
Apixaban
Apixaban Intermediates
Asenapine Intermediates
Cabozantinib S-Malate
Ceritinib Intermediates
CO-1686 intermediate 3
Dabigatran Etexilate Intermediates
Dapagliflozin Intermediates
Dasatinib intermediate
Duloxetine Intermediates
Eletriptan Intermediates
flumethasone
Ibrutinib Intermediates
Imatinib mesylate
Imiquimod Intermediates
Lapatinib
Lapatinib ditosylate
Lapatinib Intermediates
LY2835219 intermediate
Mirabegron intermediate
Olaparib
Pazopanib intermediate
Perindopril Intermediates
Posaconazole Intermediates
Poziotinib
Regorafenib
Sofosbuvir
Sofosbuvir Intermediates
Sorafenib intermediate
Tofacitinib Intermediates
Vilazodone Intermediates
VX809 Intermediates